Inhibition of hyperprogressive cancer disease induced by immune-checkpoint blockade upon co-treatment with meta-tyrosine and p38 pathway inhibitor

Overview of attention for article published in BMC Cancer, August 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 1 news outlet

twitter: 6 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 6 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 57,358 followers.

@Debunk_the_Funk @MaryanneDemasi @weldeiry @AdhesionsOrg @FatEmperor @JohnBoweActor @thecoastguy @jeffreyatucker @JanJekielek @P_McCulloughMD @ABridgen @newstart_2024 @wideawake_media @SenRonJohnson 👇

07 May 2024

Reply Repost Favourite

@MaduroPoiares @govpt @RcostaRicardo It's important to note that while some "fact checkers" may dismiss "Turbo Cancer" as a nonexistent condition, it actually refers to what is medically recognized as Hyperprogressive Disease. https://t.co/JiZBPJxr6Y

05 May 2024

Reply Repost Favourite

Another World Renoun Scientist identifies mRNA as producing Hyperprogressive Disease and is a "Evil Practices of Science." #mRNA #CDC #fauci #NIAID https://t.co/nKpwY5RWus https://t.co/15wMS2a4Qj

29 Apr 2024

Reply Repost Favourite

RT @BMC_series: A new paper in #BMCCancer explores a combined treatment that strongly inhibited tumor growth and reduced side effects: htt…

25 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.